Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinasesYing-Nan P. Chen, Nicholas Keen, Jorge García‐Fortanet et al.|Nature|2016Cited by 925
CD44posCD49fhiCD133/2hi Defines Xenograft-Initiating Cells in Estrogen Receptor–Negative Breast CancerMatthew J. Meyer, Barbara K. Vonderhaar|Cancer Research|2010Cited by 180